Risks and Liquidity (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended			12 Months Ended
	Apr. 21, 2023	Mar. 31, 2024	Apr. 30, 2023	Aug. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Unusual Risk or Uncertainty [Line Items]
Accumulated deficit					$ (320,889)	$ (274,225)
Received net proceeds of after deducting underwriting discounts, commissions and other offering expenses					$ 46,341	$ 34,400
Subsequent Event | MiMedx Group, Inc.
Unusual Risk or Uncertainty [Line Items]
Initial payment		$ 5,000
Period of net sales considered for calculating additional future payment receivable		2 years
Subsequent Event | MiMedx Group, Inc. | Maximum
Unusual Risk or Uncertainty [Line Items]
Aggregate additional future payments		$ 7,000
Subsequent Event | MiMedx Group, Inc. | Minimum
Unusual Risk or Uncertainty [Line Items]
Aggregate additional future payments		$ 3,000
Underwritten public offering
Unusual Risk or Uncertainty [Line Items]
Common stock issued and sold (in shares)	5,219,190		5,219,190
Offering price (in dollar per share)	$ 9.50		$ 9.50
Received net proceeds of after deducting underwriting discounts, commissions and other offering expenses	$ 46,300		$ 46,300
Over-Allotment Option
Unusual Risk or Uncertainty [Line Items]
Common stock issued and sold (in shares)	469,190		469,190	4,600,000
Offering price (in dollar per share)				$ 8.00
Received net proceeds of after deducting underwriting discounts, commissions and other offering expenses				$ 34,400